Medical Membranes Market

Market Outlook for Medical Membranes

Fact.MR’s medical membranes industry analysis shows that the global market was valued at US$ 2 Bn in 2020, and is projected to top a valuation of US$ 3 Bn by 2031, expanding at a CAGR of 7%. Sales of for ultrafiltration membranes are projected to reach a valuation of US$ 1 Bn by 2031, surging at a CAGR of 7% over the next ten years, with that for microfiltration membranes increasing at 6%.

Sales Analysis of Medical Membranes from 2016 to 2020 Vs Demand Outlook for 2021 to 2031

As per Fact.MR - a market research and competitive intelligence provider, the global market for medical membranes was valued at US$ 1.3 Bn in 2016 and is anticipated to expand at a CAGR of 7% to top US$ 3 Bn by 2031.

Medical membrane technology is of major importance in medical applications, in particular in a number of lifesaving treatment methods. Its major medical applications include drug delivery, tissue regeneration, artificial organs, and diagnostic devices such as medical device coatings and bio-separations.

Some of the other applications of membrane technologies, such as separation, and purification are highly in demand in the pharmaceutical industry. Medical membranes have high precision for separation and assist in the processing of products of high purity.

In addition, they provide comparatively greater selectivity toward the critical components and thus help to improve wastewater treatment.

Owing to increase in their application across various end-use industries such as biotechnology, pharmaceutical, and healthcare, the global market for medical membrane has witnessed unprecedented growth in recent years.

What are the Key Opportunities Awaiting Manufacturers of Medical Membranes?

Rise in prevalence of diseases globally, developments in biotechnology, life science, and healthcare industries, surge in demand for high-purity products, and increase in medical membrane consumption in the medical industry are some of the key driving forces of the global industry for medical membranes.

In addition, in the last few years, there have been growing cases of end-stage renal disease and diabetes due to upsurge in geriatric population and increase in the number of obese people worldwide.

The pharmaceutical, healthcare, and biotechnology industries are experiencing tremendous growth in developing countries as the ageing population rises. Furthermore, development of the healthcare industry in emerging economies is expected to provide lucrative opportunities for business growth during the forecast period.

What are the Restraints being Faced by Suppliers of Medical Membranes?

Medical membranes, though made of medical grade polymers, have to undergo in-process validation for certification. This process takes 3-6 months. After the membrane or membrane component has been validated and certified, the device that uses the membrane also needs to be certified.  

Despite high demand for medical products and devices, manufacturers are facing several regulatory barriers due to multi-layered regulations set by the FDA.

The lifespan of a particular type of membrane used in a separation process for medical application is constrained and, therefore, needs replacement after a certain period of time.

Medical membranes used in various procedures are prone to fouling, after which, they do not have the same operational excellence.

During the treatment of pharmaceutical water or during any filtration/purification process, some unwanted components such as iron, manganese, calcium, sulfate, and other ions form precipitate on the membrane surface. Damaging the properties of the membrane.

Hence, the long validation process along with high maintenance costs of medical membranes are acting as restraining factors for the growth of market.

Which Region Offers Lucrative Opportunity for Medical Membrane Providers?

Europe accounts for around 35% of the global market share for medical membranes.

Europe a leader in pharmaceutical manufacturing and dialyzer demand. Growth is fuelled by the increasing ESRD (end-stage renal failure) patient pool, rising availability of better diagnosis facilities, and high incidence and prevalence of chronic diseases such as diabetes and hypertension.

Country-wise Analysis

How is Demand for Medical Membranes Shaping Up across Developing and Developed Economies?

• The medical membranes market in the U.S. is estimated to reach a valuation of US$ 735 Mn in the year 2021.
• China, the world’s second largest economy, is forecast to reach an estimated market size of US$ 350 Mn in the year 2031, trailing a CAGR of 9% through the analysis period.
• Among the other noteworthy geographic markets are Japan and Canada, each forecast to expand at CAGRs of 4% and 6%, respectively, over the next ten years.
• Within Europe, the market in Germany is forecast to expand at approximately 7% CAGR, while the Rest of European market will reach US$ 386 Mn by the end of 2031.

These markets are benefiting from the rise in need for high purity products for meeting the needs of biotechnological advancements, increase in disease prevalence, and growth of the healthcare and life science industry.

Other emerging applications include the venting and gas filtration, sample preparation and infusion therapy, pre-filtration, and sterile filtration among others. In addition, medical membranes are finding extensive application across the haemodialysis and pharmaceutical filtration process.

Growth in number of patients who are suffering from end-stage renal disease (ESRD) needing dialysis is pushing up demand for membranes for blood purification and filtration. As a result, there is an increased demand for products with high purity due to the expansion of healthcare and pharmaceutical industries, while contributing growth of the medical membranes market globally.

Category-wise Analysis

Why Has Demand for Polysulfone and Polyether Sulfone Membranes Increased Over the Past Years?

Polysulfone (PSU) & polyether sulfone (PESU) membranes have emerged as the largest segment in the global market for medical membranes.

Widespread use of this form of material to remove particulates during general filtration and its low protein and drug binding characteristics make it ideal for various end-user sectors such as the biotechnology, pharmaceutical, life sciences, and healthcare industries.

This is the main reason for why polysulfone and polyether sulfone membranes are contributing to revenue generated in the global market.

Which Technology Dominates the Industry for Medical Membranes?

Demand for nanofiltration medical membranes is expected to reach a valuation of US$ 730 Mn by 2031.

Nanofiltration technology dominates the global market for medical membranes. This is attributed to the fact that, with increase in flow rates, nanofiltration is achieved at reduced operating pressures.

Applicability of nanofiltration in areas such as pharmaceuticals and fine chemicals has been extended by research & development of solvent-stable membranes, thus driving the growth of nanofiltration technology.

Which Application of Medical Membranes is the Highest in Terms of Revenue?

Pharmaceutical filtration has garnered the largest share of around 30%, in terms of revenue.

High rate of occurrence of renal diseases, advances in medical technology, development of pharmaceutical & healthcare industries, and rise in demand for high-purity materials & medicines are driving the growth of the pharmaceutical filtration segment in the global market.

Competitive Landscape

Key players are adopting several organic and inorganic growth strategies to strengthen their foothold in the market. Many companies expanded their production facilities and acquired other businesses to strengthen their position in the global market.

Some of the key developments are:

• In 2017, 3M Company (US) made an investment of US$ 40 Mn to expand its dialysis membrane production facility. This expansion will help company to increase its customer base and strengthen its foothold in the market.
• In August 2017, Merck Millipore (US) acquired Natrix Separation (Canada), which is hydrogel membrane provider. This acquisition will help Merck Millipore (US) in increasing its product portfolio, customer base, and strengthen its foothold in North America.
• In December 2017, Asahi Kasei Medical announced the construction of a new plant for the spinning of cellulose hollow fiber membranes for its virus removal filters called Planova.

In September 2016, Sartorius launched a PES membrane, which is integrated into the sterile Sartocon benchtop and production scale filtration assemblies.

Medical Membranes Market Report Scope

Attribute	Details
Forecast Period	2021-2031
Historical Data Available for	2016-2020
Market Analysis	US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered	North America Europe Asia Pacific Central & South America Middle East & Africa
Key Countries Covered	USA Canada Germany France the UK Russia Italy China Japan South Korea India Australia  Middle East Latin America
Key Market Segments Covered	Material Process Technology Application Region
Key Companies Profiled	Koninklijke Philips N.V Inogen BOC Healthcare Precision Medical Luxfer Group Cryofab Responsive Respiratory Atlas Copco GCE group High Vacuum Maintenance (HVM) S.R.L.
Pricing	Available upon Request

Key Market Segments Covered in Medical Membranes Industry Research

• By Material

  • Polysulfone PSU & Polyethersulfone PESU
  • Hydrophilic polyvinylidene fluoride PVDF
  • Polytetrafluoroethylene PTFE
  • Polypropylene PP
  • Polyethylene
  • Modified Acrylics

• By Process Technology

  • Ultrafiltration
  • Microfiltration
  • Nanofiltration
  • Reverse Osmosis
  • Dialysis
  • Gas Filtration

• By Application

  • Medical Membranes Used in Pharmaceutical Filtration
  • Medical Membranes Used in Haemodialysis
  • Medical Membranes Used in Drug Delivery
  • Medical Membranes Used in IV Infusion & Sterile Filtration
  • Medical Membranes Used in Bio-artificial Processes